Luis Carlos Vesga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Luis Carlos Vesga has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Stelia Carolina Mendez-Sanchez
Grupo de Investigación en Bioquímica y Microbiología (GIBIM), Escuela de Química, Universidad Industrial de Santander. Parque tecnológico y de investigaciones, Guatiguará Km 2 Vía El Refugio, 681012, Piedecuesta, Santander, Colombia
7 shared publications - Arnold Rafael Romero Bohorquez
Grupo de Investigación en Compuestos Orgánicos de Interés Medicinal (CODEIM), Escuela de Química, Universidad Industrial de Santander, Bucaramanga, Colombia
3 shared publications - Jonny Edward Duque
Centro de Investigaciones en Enfermedades Tropicales—CINTROP, Facultad de Salud, Escuela de Medicina, Departamento de Ciencias Básicas, Universidad Industrial de Santander, Guatiguará Technology and Research Park, Km 2 Vía El Refugio, Piedecuesta 681018, Santander, Colombia
3 shared publications - Antti Poso
University of Eastern Finland
2 shared publications Cristian C. Bernal
Grupo de Investigación en Bioquímica y Microbiología GIBIM, Escuela de Química, Universidad Industrial de Santander, Bucaramanga, Colombia
2 shared publicationsDiogo Henrique Kita
Pharmaceutical Sciences Graduate Program, Laboratory of Cancer Drug Resistance, Federal University of Paraná, Curitiba, PR, Brazil
2 shared publications
Latest Publications
- 10 March 2025
- Published by Taylor & Francis
- p. 171-190
High-Throughput Screening to Detect Natural Compounds with Pesticidal Properties
Developing new, biocompatible, and safe pesticides is essential due to the harmful effects of traditional pesticides on human health and the environment. These synthetic chemicals can cause various health issues, from mild irritations to severe conditions like respiratory problems, neuropsychiatric disorders, cancer, and reproductive harm. Consequently, researchers have been focusing on formulating new and efficient biopesticides. Computational approaches have become important tools in identifying new bioactive compounds that target novel and interesting molecular targets such as mitochondrial proteins. Mitochondria are not only the powerhouse of the cell but also play crucial roles in cell death processes and serve as intracellular calcium reservoirs, making them key organelles for pesticide development. The identification of bioactive compounds using computational approaches such as homology modeling, ligand-based screening, structure-based screening, molecular docking, and molecular dynamics simulations can save both time and cost. In this chapter, we show that once lead compounds are identified by following a workflow base on virtual screening, in vitro and in vivo assays can measure their biological activity. Besides, electroantennography is emerging as a vital tool for developing new repellents as an alternative to test these lead compounds. Briefly, combining computational approaches with in vitro, in vivo, and electroantennography assays can provide valuable insights for animal and human health and for controlling pests in the agricultural industry.
- 10 March 2025
- Published by Taylor & Francis
- p. 171-190
High-Throughput Screening to Detect Natural Compounds with Pesticidal Properties
Developing new, biocompatible, and safe pesticides is essential due to the harmful effects of traditional pesticides on human health and the environment. These synthetic chemicals can cause various health issues, from mild irritations to severe conditions like respiratory problems, neuropsychiatric disorders, cancer, and reproductive harm. Consequently, researchers have been focusing on formulating new and efficient biopesticides. Computational approaches have become important tools in identifying new bioactive compounds that target novel and interesting molecular targets such as mitochondrial proteins. Mitochondria are not only the powerhouse of the cell but also play crucial roles in cell death processes and serve as intracellular calcium reservoirs, making them key organelles for pesticide development. The identification of bioactive compounds using computational approaches such as homology modeling, ligand-based screening, structure-based screening, molecular docking, and molecular dynamics simulations can save both time and cost. In this chapter, we show that once lead compounds are identified by following a workflow base on virtual screening, in vitro and in vivo assays can measure their biological activity. Besides, electroantennography is emerging as a vital tool for developing new repellents as an alternative to test these lead compounds. Briefly, combining computational approaches with in vitro, in vivo, and electroantennography assays can provide valuable insights for animal and human health and for controlling pests in the agricultural industry.
- 7 March 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 217,p. e67146
Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays
Mitochondria are often referred to as the cell's powerhouse due to their crucial role in energy production through the electron transport chain (ETC). However, their significance extends far beyond energy production. Dysregulation of mitochondrial bioenergetics can trigger intracellular cascades that impact health and cellular function. Given their physiological importance, there is growing interest in exploring the pharmacological potential of mitochondrial function for developing new therapies and bioproducts. Modulating mitochondrial bioenergetics could provide innovative approaches to address challenges such as neurodegenerative disorders, metabolic diseases, and cancer, as well as to develop bioproducts for controlling pests and vector-borne diseases. This work presents a method for assessing the effects of xenobiotics on the electron transport chain (ETC) using various substrates, including glutamate and NADH for complex I, succinate for complex II, and cytochrome c (both oxidized and reduced) for complexes III and IV. This methodology allows the activation or inhibition of electron transport through mitochondrial complexes to be evaluated using a respirometer and spectrophotometer. The mitochondria can be sourced from isolated mitochondria, fragmented cells, or homogenized tissue from various species. In the laboratory, mitochondrial function has been analyzed in Aedes aegypti and Wistar rats, but this method is also applicable to other species, such as Rhipicephalus microplus and Rhodnius prolixus. This approach provides the basis for theorizing about the existence of uncoupler proteins and species-specific oxidizable substrate preferences influenced by their unique energetic demands. Recent findings offer valuable insights into innovative bioinsecticide design strategies that target mitochondrial function, holding significant potential for effectively controlling vector-borne diseases and pest infestations.
- 7 March 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 217,p. e67146
Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays
Mitochondria are often referred to as the cell's powerhouse due to their crucial role in energy production through the electron transport chain (ETC). However, their significance extends far beyond energy production. Dysregulation of mitochondrial bioenergetics can trigger intracellular cascades that impact health and cellular function. Given their physiological importance, there is growing interest in exploring the pharmacological potential of mitochondrial function for developing new therapies and bioproducts. Modulating mitochondrial bioenergetics could provide innovative approaches to address challenges such as neurodegenerative disorders, metabolic diseases, and cancer, as well as to develop bioproducts for controlling pests and vector-borne diseases. This work presents a method for assessing the effects of xenobiotics on the electron transport chain (ETC) using various substrates, including glutamate and NADH for complex I, succinate for complex II, and cytochrome c (both oxidized and reduced) for complexes III and IV. This methodology allows the activation or inhibition of electron transport through mitochondrial complexes to be evaluated using a respirometer and spectrophotometer. The mitochondria can be sourced from isolated mitochondria, fragmented cells, or homogenized tissue from various species. In the laboratory, mitochondrial function has been analyzed in Aedes aegypti and Wistar rats, but this method is also applicable to other species, such as Rhipicephalus microplus and Rhodnius prolixus. This approach provides the basis for theorizing about the existence of uncoupler proteins and species-specific oxidizable substrate preferences influenced by their unique energetic demands. Recent findings offer valuable insights into innovative bioinsecticide design strategies that target mitochondrial function, holding significant potential for effectively controlling vector-borne diseases and pest infestations.
- Open Access
- 14 April 2022
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 90 (2) , 24
Repurposing of Four Drugs as Anti-SARS-CoV-2 Agents and Their Interactions with Protein Targets
Although there are existing vaccines against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), new COVID-19 cases are increasing due to low immunization coverage and the emergence of new variants. For this reason, new drugs to treat and prevent severe COVID-19 are needed. Here, we provide four different FDA-approved drugs against SARS-CoV-2 proteins involved in the entry and replication process, aiming to identify potential drugs to treat COVID-19. We use the main protease (Mpro), the spike glycoprotein (S protein), and RNA-dependent RNA polymerase (RdRp) as protein targets for anti- SARS-CoV-2 drugs. In our constructed database, we selected different drugs against each target (Mpro, S protein, and RdRp) based on their common interactions with relevant residues involved in viral entry at the host cell and replication. Furthermore, their stability inside the binding pocket, as well as their predicted binding-free energy, allow us to provide new insight into the possible drug repurposing of viomycin (interacting with Mpro) due to its interactions with key residues, such as Asn 143, Glu 166, and Gln 189 at the same time as hesperidin (interacting with the S protein) is interacting with residues Tyr 449, Ser 494, and Thr 500, keeping inside the predicted binding pocket, as well as interacting with residues in different variants of concern. Finally, we also suggest nystatin and elvitegravir (interacting with RdRp) as possible drugs due to their stability within the predicted pocket along the simulation and their interaction with key residues, such as Asp 760, Asp 761, and Asp 618. Altogether our results provide new knowledge about the possible mechanism of the inhibition of viomycin, hesperidin, elvitegravir, and nystatin to inhibit the viral life cycle of SARS-CoV-2 and some of its variants of concern (VOC). Additionally, some iodide-based contrast agents were also found to bind the S protein strongly, i.e., iohexol (−58.99 Kcal/mol), iotrolan (−76.19 Kcal/mol), and ioxilan (−62.37 Kcal/mol). Despite the information we report here as the possible strong interaction between these contrast agents and the SARS-CoV-2′s S protein, Mpro, and RdRp, we believe that further investigation, including chemical modifications in their structures, are needed for COVID-19 treatment.
- 14 April 2022
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 90 (2) , 24
Open AccessRepurposing of Four Drugs as Anti-SARS-CoV-2 Agents and Their Interactions with Protein Targets
Although there are existing vaccines against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), new COVID-19 cases are increasing due to low immunization coverage and the emergence of new variants. For this reason, new drugs to treat and prevent severe COVID-19 are needed. Here, we provide four different FDA-approved drugs against SARS-CoV-2 proteins involved in the entry and replication process, aiming to identify potential drugs to treat COVID-19. We use the main protease (Mpro), the spike glycoprotein (S protein), and RNA-dependent RNA polymerase (RdRp) as protein targets for anti- SARS-CoV-2 drugs. In our constructed database, we selected different drugs against each target (Mpro, S protein, and RdRp) based on their common interactions with relevant residues involved in viral entry at the host cell and replication. Furthermore, their stability inside the binding pocket, as well as their predicted binding-free energy, allow us to provide new insight into the possible drug repurposing of viomycin (interacting with Mpro) due to its interactions with key residues, such as Asn 143, Glu 166, and Gln 189 at the same time as hesperidin (interacting with the S protein) is interacting with residues Tyr 449, Ser 494, and Thr 500, keeping inside the predicted binding pocket, as well as interacting with residues in different variants of concern. Finally, we also suggest nystatin and elvitegravir (interacting with RdRp) as possible drugs due to their stability within the predicted pocket along the simulation and their interaction with key residues, such as Asp 760, Asp 761, and Asp 618. Altogether our results provide new knowledge about the possible mechanism of the inhibition of viomycin, hesperidin, elvitegravir, and nystatin to inhibit the viral life cycle of SARS-CoV-2 and some of its variants of concern (VOC). Additionally, some iodide-based contrast agents were also found to bind the S protein strongly, i.e., iohexol (−58.99 Kcal/mol), iotrolan (−76.19 Kcal/mol), and ioxilan (−62.37 Kcal/mol). Despite the information we report here as the possible strong interaction between these contrast agents and the SARS-CoV-2′s S protein, Mpro, and RdRp, we believe that further investigation, including chemical modifications in their structures, are needed for COVID-19 treatment.
- 22 March 2022
- Published by Taylor & Francis in Journal of Essential Oil Research
- Vol. 34 (3) , 233-239
Cymbopogon flexuosus (nees ex steud.) w. watson essential oil effect on mitochondrial bioenergetics
Cymbopogon flexuosus is a medicinal plant with various biological activities. Although its essential oil (EO) is widely used, the effect of C. flexuosus EO on mitochondrial bioenergetics has not been completely elucidated. Here, we report the effect of C. flexuosus EO on electron transport through the mitochondrial respiratory chain using isolated mitochondria from liver rats. The EO decreases the oxygen consumption rate up to −20% at 10 ppm, and −17% at 25 ppm using glutamate and succinate, respectively. The C. flexuosus EO inhibits the NADH oxidase (34%), succinate oxidase (53%), succinate dehydrogenase (44%), and cytochrome c oxidase (69%) activities at 10 ppm, which indicates a robust inhibitory effect on the electron transport chain. Our results show the inhibitory effect of C. flexuosus EO on electron transport through complex II and IV and suggest that this EO could be used as a potential drug to treat mitochondrial diseases, including cancer.
- 22 March 2022
- Published by Taylor & Francis in Journal of Essential Oil Research
- Vol. 34 (3) , 233-239
Cymbopogon flexuosus (nees ex steud.) w. watson essential oil effect on mitochondrial bioenergetics
Cymbopogon flexuosus is a medicinal plant with various biological activities. Although its essential oil (EO) is widely used, the effect of C. flexuosus EO on mitochondrial bioenergetics has not been completely elucidated. Here, we report the effect of C. flexuosus EO on electron transport through the mitochondrial respiratory chain using isolated mitochondria from liver rats. The EO decreases the oxygen consumption rate up to −20% at 10 ppm, and −17% at 25 ppm using glutamate and succinate, respectively. The C. flexuosus EO inhibits the NADH oxidase (34%), succinate oxidase (53%), succinate dehydrogenase (44%), and cytochrome c oxidase (69%) activities at 10 ppm, which indicates a robust inhibitory effect on the electron transport chain. Our results show the inhibitory effect of C. flexuosus EO on electron transport through complex II and IV and suggest that this EO could be used as a potential drug to treat mitochondrial diseases, including cancer.
- 1 January 2022
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 351, 109718
A new porphyrin as selective substrate-based inhibitor of breast cancer resistance protein (BCRP/ABCG2)
- 1 January 2022
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 351, 109718
A new porphyrin as selective substrate-based inhibitor of breast cancer resistance protein (BCRP/ABCG2)
- 27 September 2021
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 30 (11) , 1-17
Tetrahydroquinoline/4,5-dihydroisoxazole hybrids with a remarkable effect over mitochondrial bioenergetic metabolism on melanoma cell line B16F10
- 27 September 2021
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 30 (11) , 1-17
Tetrahydroquinoline/4,5-dihydroisoxazole hybrids with a remarkable effect over mitochondrial bioenergetic metabolism on melanoma cell line B16F10
- 24 May 2021
- Published by Wiley in Insect Molecular Biology
- Vol. 30 (5) , 461-471
Spatial control of gene expression in flies using bacterially derived binary transactivation systems
Controlling gene expression is an instrumental tool for biotechnology, as it enables the dissection of gene function, affording precise spatial–temporal resolution. To generate this control, binary transactivational systems have been used employing a modular activator consisting of a DNA binding domain(s) fused to activation domain(s). For fly genetics, many binary transactivational systems have been exploited in vivo ; however, as the study of complex problems often requires multiple systems that can be used in parallel, there is a need to identify additional bipartite genetic systems. To expand this molecular genetic toolbox, we tested multiple bacterially derived binary transactivational systems in Drosophila melanogaster including the p ‐CymR operon from Pseudomonas putida , PipR operon from Streptomyces coelicolor , TtgR operon from Pseudomonas putida and the VanR operon from Caulobacter crescentus . Our work provides the first characterization of these systems in an animal model in vivo . For each system, we demonstrate robust tissue‐specific spatial transactivation of reporter gene expression, enabling future studies to exploit these transactivational systems for molecular genetic studies.
- 24 May 2021
- Published by Wiley in Insect Molecular Biology
- Vol. 30 (5) , 461-471
Spatial control of gene expression in flies using bacterially derived binary transactivation systems
Controlling gene expression is an instrumental tool for biotechnology, as it enables the dissection of gene function, affording precise spatial–temporal resolution. To generate this control, binary transactivational systems have been used employing a modular activator consisting of a DNA binding domain(s) fused to activation domain(s). For fly genetics, many binary transactivational systems have been exploited in vivo ; however, as the study of complex problems often requires multiple systems that can be used in parallel, there is a need to identify additional bipartite genetic systems. To expand this molecular genetic toolbox, we tested multiple bacterially derived binary transactivational systems in Drosophila melanogaster including the p ‐CymR operon from Pseudomonas putida , PipR operon from Streptomyces coelicolor , TtgR operon from Pseudomonas putida and the VanR operon from Caulobacter crescentus . Our work provides the first characterization of these systems in an animal model in vivo . For each system, we demonstrate robust tissue‐specific spatial transactivation of reporter gene expression, enabling future studies to exploit these transactivational systems for molecular genetic studies.
- Open Access
- 12 April 2021
- Published by Wiley in ChemMedChem
- Vol. 16 (17) , 2686-2694
Tetrahydroquinoline/4,5‐Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)
Multidrug resistance (MDR) is one of the major factors in the failure of many chemotherapy approaches. In cancer cells, MDR is mainly associated with the expression of ABC transporters such as P‐glycoprotein, MRP1 and ABCG2. Despite major efforts to develop new selective and potent inhibitors of ABC drug transporters, no ABCG2‐specific inhibitors for clinical use are yet available. Here, we report the evaluation of sixteen tetrahydroquinoline/4,5‐dihydroisoxazole derivatives as a new class of ABCG2 inhibitors. The affinity of the five best inhibitors was further investigated by the vanadate‐sensitive ATPase assay. Molecular modelling data, proposing a potential binding mode, suggest that they can inhibit the ABCG2 activity by binding on site S1, previously reported as inhibitors binding region, as well targeting site S2, a selective region for substrates, and by specifically interacting with residues Asn436, Gln398, and Leu555. Altogether, this study provided new insights into THQ/4,5‐dihydroisoxazole molecular hybrids, generating great potential for the development of novel most potent ABCG2 inhibitors.
- 12 April 2021
- Published by Wiley in ChemMedChem
- Vol. 16 (17) , 2686-2694
Open AccessTetrahydroquinoline/4,5‐Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)
Multidrug resistance (MDR) is one of the major factors in the failure of many chemotherapy approaches. In cancer cells, MDR is mainly associated with the expression of ABC transporters such as P‐glycoprotein, MRP1 and ABCG2. Despite major efforts to develop new selective and potent inhibitors of ABC drug transporters, no ABCG2‐specific inhibitors for clinical use are yet available. Here, we report the evaluation of sixteen tetrahydroquinoline/4,5‐dihydroisoxazole derivatives as a new class of ABCG2 inhibitors. The affinity of the five best inhibitors was further investigated by the vanadate‐sensitive ATPase assay. Molecular modelling data, proposing a potential binding mode, suggest that they can inhibit the ABCG2 activity by binding on site S1, previously reported as inhibitors binding region, as well targeting site S2, a selective region for substrates, and by specifically interacting with residues Asn436, Gln398, and Leu555. Altogether, this study provided new insights into THQ/4,5‐dihydroisoxazole molecular hybrids, generating great potential for the development of novel most potent ABCG2 inhibitors.
- 27 January 2020
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 29 (4) , 675-689
Synthesis and anticancer activity of new tetrahydroquinoline hybrid derivatives tethered to isoxazoline moiety
- 27 January 2020
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 29 (4) , 675-689
Synthesis and anticancer activity of new tetrahydroquinoline hybrid derivatives tethered to isoxazoline moiety